Cargando…
Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fraction
AIMS: We aim to assess the theoretical impact of the atrial flow regulator (AFR) on survival in heart failure. METHODS AND RESULTS: The prospective, multicentre, open‐label, non‐randomised PRELIEVE study (NCT 03030274) assessed the safety and efficacy of the Occlutech AFR device in patients with sym...
Autores principales: | Lauder, Lucas, Bergmann, Martin W., Paitazoglou, Christina, Özdemir, Ramazan, Iliadis, Christos, Bartunek, Jozef, Lauten, Alexander, Keller, Thomas, Weber, Stephan, Sievert, Horst, Anker, Stefan D., Mahfoud, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375067/ https://www.ncbi.nlm.nih.gov/pubmed/37312287 http://dx.doi.org/10.1002/ehf2.14384 |
Ejemplares similares
-
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
por: Böhm, Michael, et al.
Publicado: (2022) -
Mitral Valve Repair of Atrial Functional Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction
por: Balogh, Zsuzsanna, et al.
Publicado: (2020) -
Aortic thoracic neuromodulation in heart failure with preserved ejection fraction
por: Paolisso, Pasquale, et al.
Publicado: (2022) -
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019) -
Left Atrial Ejection Force as a Marker for the Diagnosis of Heart Failure with Preserved Ejection Fraction
por: Hafez, Mohamed Saber, et al.
Publicado: (2021)